Glassman Wealth Services Intercept Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$13.37 - $17.79 $173 - $231	-13 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $185 - $253	13 New	13 $0
Q3 2020 Nov 09, 2020	SELL	$39.09 - $53.44 $156 - $213	-4 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$46.7 - $92.04 $4,670 - $9,204	-100 Reduced 96.15%	4 $0
Q1 2020 May 12, 2020	BUY	$48.35 - $118.68 $193 - $474	4 Added 4.0%	104 $7,000
Q4 2019 Feb 07, 2020	BUY	$57.36 - $124.1 $5,736 - $12,410	100 New	100 $12,000
Q3 2019 Nov 01, 2019	SELL	$58.69 - $80.46 $645 - $885	-11 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$91.83 - $120.68 $1,010 - $1,327	11 New	11 $1,000
Q1 2018 May 01, 2018	SELL	$52.72 - $67.25 $210 - $269	-4 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$58.2 - $72.76 $232 - $291	4	4 $0

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.